Transparent and reproducible reports of economic evaluations of clinical pharmacy services: A goal for the future?

American Journal of Health-System Pharmacy

Volumn 66, Issue 5, 2009, Pages 442-443

  Hoffman, James M ^a   Meek, Patrick D ^b   Touchette, Daniel R ^c   Vermeulen, Lee C ^d   Schumock, Glen T ^c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECONOMIC ASPECT; EVALUATION; HEALTH CARE COST; HOSPITAL DEPARTMENT; LETTER; PRIORITY JOURNAL; COST BENEFIT ANALYSIS; COST CONTROL; ECONOMICS; HOSPITAL PHARMACY; HUMAN; METHODOLOGY; NOTE; ORGANIZATION AND MANAGEMENT; PHARMACOECONOMICS; REPRODUCIBILITY; UNITED STATES;

COST SAVINGS; COST-BENEFIT ANALYSIS; ECONOMICS, PHARMACEUTICAL; HUMANS; PHARMACY SERVICE, HOSPITAL; REPRODUCIBILITY OF RESULTS; UNITED STATES;

EID: 63049136050     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080435     Document Type: Letter

References (14)

1. De Rijdt T, Willems L, Simoens S. Economic effects of clinical pharmacy interventions: a literature review. Am J Health-Syst Pharm. 2008; 65:1161-72.
2. Eden J, Wheatley B, McNeil B et al. In: Committee on Reviewing Evidence to Identify Highly Effective Clinical Services, eds. Knowing what works in health care: a roadmap for the nation. Institute of Medicine. Washington, D.C: National Academies Press; 2008.
3. Schumock GT, Meek PD, Ploetz PA et al. Economic evaluations of clinical pharmacy services-1988-1995. The Publications Committee of the American College of Clinical Pharmacy. Pharmacotherapy. 1996; 16:1188-208.
4. Schumock GT, Butler MG, Meek PD et al. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy. 2003; 23:113-32.
5. Perez A, Doloresco F, Hoffman JM et al. Economic evaluations of clinical pharmacy services: 2001-2005. Pharmacotherapy. 2008; 28:285e-323e. www.pharmacotherapy.org/pdf/free/pharm281 l-Perez-EconEval.pdf (accessed 2009 Jan 27).
6. Carling P, Fung T, Killion A et al. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol. 2003; 24:699-706.
7. Streetman DS, Nafziger AN, Destache CJ et al. Individualized pharmacokinetic monitoring results in less amino-glycoside-associated nephrotoxicity and fewer associated costs. Pharmacotherapy. 2001;21:443-51.
8. Bernsten C, Björkman I, Caramona M et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging. 2001; 18:63-77.
9. McLean W, Gillis J, Waller R. The BC Community Pharmacy Asthma Study: a study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Can Respir J. 2003; 10:195-202.
10. Okamoto MP, Nakahiro RK. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy. 2001; 21:1337-44.
11. Roberts MS, Stokes JA, King MA et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol. 2001;51:257-65.
12. Sturgess IK, McElnay JC, Hughes CM et al. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci. 2003; 25:218-26.
13. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ. 1996;313:275-83.
14. CONSORT. CONSORT statement, www. consort-statement.org/ (accessed 2008 Jul 18).